BiliaryTractCancer near Brooksville, FL

Care Philosophy: My medical care philosophy is simple. Cancer patients do not deserve their troubles. We all appreciate straight talk. Often Community Care is very helpful to patients. Other times, when academic referral offers more proper care, I enjoy facilitating transfers and collaborations for advancement of patient care.

Care Philosophy: Dr Dilling's primary clinical focus is the radiotherapeutic treatment of thoracic malignancies.Dr Dilling's research interests focus around the use of Big Data and artificial intelligence to generate novel insights into patient treatment and toxicity. To that end, he has curated a database of thousands of patients who have received radiotherapy to the lung at Moffitt (millions of data points). This data set is among the largest/most complex clinical data sets on radiotherapy patients in the world.

Care Philosophy: My goal is to provide each patient with quality surgical care centered on experience, precision, safety and compassion.

Biography: Dr. Aaron Denson, MD is an Oncology Specialist who practices in Brooksville, FL. He is 39 years old and has been practicing for 20 years. Dr. Aaron Denson, MD is affiliated with HCA Florida Oak Hill Hospital.

Care Philosophy: Dr G Daniel Grass is an Assistant Member and clinical-investigator in the Department of Radiation Oncology. Dr Grass received his MD and PhD in Molecular and Cellular Biology and Pathobiology from the Medical University of South Carolina, Medical Scientist Training Program. He completed a Radiation Oncology Residency at Moffitt Cancer Center/University of South Florida. He is focused on treating patients with genitourinary malignancies (e.g. prostate, bladder, kidney, penile, ureter, testicular) by implementing novel approaches with leading edge radiation technologies.

Care Philosophy: Dr Jonathan Zager is the Chief Academic Officer and a surgical oncologist and Senior Member in the Departments of Cutaneous Oncology and Sarcoma at Moffitt Cancer Center. Dr Zager is the Director of Regional Therapies at Moffitt's Donald A Adam Comprehensive Melanoma Research Center. Dr Zager is the Chair of the Department of Oncologic Sciences and a Professor of Surgery at the University of South Florida, Morsani School of Medicine. Dr Zager's research and clinical interests include the regional therapy treatment of cutaneous melanoma and non-melanoma skin cancers, soft tissue sarcomas. Dr Zager is internationally known for the management and study of locoregionally recurrent melanoma, non-melanoma skin cancer and soft tissue sarcoma.

Care Philosophy: Dr Ricardo Gonzalez is a surgical oncologist and Chair of the Sarcoma Department at Moffitt Cancer Center. He also serves as a member of the Cutaneous Program at Moffitt Cancer Center. He is an associate professor at the University Of South Florida College Of Medicine's Department of Oncologic Sciences and Department of Surgery. Dr Gonzalez' research and clinical interests include outcomes analyses and management of patients with soft tissue sarcomas, retroperitoneal sarcomas, desmoid tumors, gastrointestinal stromal tumors (GIST) and head and neck melanoma.

Care Philosophy: At Florida Cancer Specialists & Research Institute you will find experienced and compassionate doctors you can trust to treat your unique cancer. Our physicians share a passion for delivering exceptional and personalized care for all forms of cancer and blood disorders, close to home. From genetic screening to immunotherapies and access to clinical trials, our top-ranked cancer experts provide the newest and most advanced treatments available increasing cure rates and extending lives. No other community-based oncology practice in Florida matches the clinical trial opportunities we offer. The majority of new cancer drugs approved for use in the U.S. in recent years were studied in clinical trials with FCS participation, prior to approval. Every interaction is focused on each patient's experience and well-being to minimize disruption to daily life. Beginning with your first appointment, our dedicated FCS team provides expert guidance and support at every step of your cancer journey.

Biography: Dr. Craig E. Grossman is a radiation oncologist at Tampa General Hospital (TGH). Before coming to TGH, Dr. Grossman accumulated an extensive range of professional and academic experiences. Most recently, he served as an Assistant Member in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center in New York, and and trained radiation therapists and dosimetrists as a Clinical Assistant Professor in the School of Health Technology and Management at Stony Brook University in Stony Brook, New York.Dr. Grossman has shared his expertise on a variety of radiation oncology topics through lectures at international meetings, hospitals and universities, and in the community. He has also contributed to the development of innovative radiation treatments, as well as published national guidelines related to genitourinary cancer (i.e. prostate, bladder, testicular) and gynecology cancer (i.e. endometrial, cervix, vagina, vulva) management. He is an expert in the treatment of prostate cancer with brachytherapy and stereotactic body radiotherapy (SBRT) among other treatment modalities, as well as treating women with various radiation techniques for their gynecologic cancer. Dr. Grossman has both clinical and research interests in sexual medicine, minimizing radiation-related side effects, and new technologies to treat cancer to improve cure rates.

Care Philosophy: Dr Wuthrick specializes in radiation therapy for skin cancers such as melanoma, Merkel cell carcinoma, squamous cell carcinoma, and basal cell carcinoma. He is also clinically interested in gastrointestinal cancers, including esophagealstomach andliver cancers, and cancers of the pancreas, colon, rectum and anus. Dr Wuthrick is interested in the combination of high dose per fraction radiation therapy and immunotherapy in melanoma and Merkel cell carcinoma. He is involved in numerous early phase clinical trials exploring the role of MAPK pathway inhibitors with radiation therapy.